Group One Trading
APYX icon

Group One Trading’s Apyx Medical APYX Stock Holding History

Group One Trading’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.96K Sell
2,700
-2,200
-45% -$8.22K ﹤0.01% 6376
2025
Q4 		$17.1K Buy
+4,900
New +$17.1K ﹤0.01% 6473
2023
Q3 		– Sell
-1,300
Closed -$6.54K – 7611
2023
Q2 		$6.54K Buy
+1,300
New +$6.59K ﹤0.01% 6595
2022
Q3 		– Sell
-200
Closed -$1K – 7509
2022
Q2 		$1K Hold
200
– – ﹤0.01% 7508
2022
Q1 		$1K Buy
+200
New +$1.97K ﹤0.01% 7798
2021
Q2 		– Sell
-1,300
Closed -$126K – 8105
2021
Q1 		$126K Buy
+1,300
New +$13K ﹤0.01% 5438
2017
Q3 		– Sell
-400
Closed -$1K – 4784
2017
Q2 		$1K Buy
+400
New +$983 ﹤0.01% 4621

Other funds holding APYX

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $9.23B AUM 27.52% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return

Group One Trading's APYX Position: Q1 2026 in Review

Group One Trading sold out of Apyx Medical (APYX) in Q1 2026, closing a stake of 11,444 shares — an estimated $42.8K sold.

Group One Trading first reported a position in APYX in Q2 2017 and held it in 11 quarters. The position peaked at $40.1K in Q4 2025. 67 funds tracked by Wall St. Rank hold APYX as of Q1 2026.

  • Group One Trading reported no remaining Apyx Medical position as of Q1 2026 after selling out during the quarter.
  • Group One Trading sold 11,444 Apyx Medical shares in Q1 2026, an estimated $42.8K.
  • Group One Trading first reported a position in Apyx Medical in Q2 2017 and held it in 11 quarters.
  • Group One Trading's Apyx Medical position peaked at $40.1K in Q4 2025.
  • 67 funds tracked by Wall St. Rank held Apyx Medical as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.